It is a pharma private limited company based in Andheri East, Mumbai, Maharashtra, India, established in 2019.
2019 | Andheri East, Mumbai, Maharashtra, India | ActiveTan-Indo Pharma Private Limited, a active private limited company, was established on 22 January 2019 in Andheri East, Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2019PTC320012. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Krishna Narsingrao Pimple (Director), Sidhant Krishna Pimple (Director). Past directors included Siddarth Jambukumar Jain. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at 101 Kushwah Chambers, Makwana Road, Opp Apurva Industrial Estate, Marol,, Andheri East, Mumbai, Maharashtra, 400059.
U74999MH2019PTC320012
320012
22 January 2019
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Tan-Indo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Narsingrao Pimple | Director | 22 Jan 2019 | Current |
| Sidhant Krishna Pimple | Director | 22 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cisb Bennet Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.26% decrease in profit. The company's net worth dipped by a decrease of 2.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Tan-Indo Pharma had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Tan-Indo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tan-Indo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tan-Indo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Tan-Indo Pharma Private Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was documented.
Tan-Indo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity Sidhant Krishna Pimple was appointed as a Director was appointed as a Director on 22 Aug 2024 & has been associated with this company since 1 year 4 months . was completed.
The activity Krishna Narsingrao Pimple was appointed as a Director was appointed as a Director on 22 Jan 2019 & has been associated with this company since 6 years 11 months . was completed.
Tan-Indo Pharma Private Limited was registered on 22 Jan 2019 with Roc Mumbai & aged 6 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Tan-Indo Pharma Private Limited is U74999MH2019PTC320012.
Tan-Indo Pharma Private Limited is headquartered at 101 Kushwah Chambers, Makwana Road, Opp Apurva Industrial Estate, Marol,, Andheri East, Mumbai, Maharashtra, 400059.
Tan-Indo Pharma Private Limited was incorporated on 22 January 2019.
The current directors of Tan-Indo Pharma Private Limited are
The primary industry of Tan-Indo Pharma Private Limited is Pharma.
Tan-Indo Pharma Private Limited is unlisted.
The authorized capital of Tan-Indo Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Tan-Indo Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX